Detecting in utero drug exposure to marijuana (tetrahydrocannabinol) up to 5 months before birth
TRYPA - Overview: Tryptase, Autopsy, Serum
Evaluation of autopsy cases in which anaphylaxis in the context of allergen exposure or mast cell activation is a suspected cause of death
TCL1A - Overview: T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Immunostain, Technical Component Only
Identification of T-cell leukemia and lymphoma protein overexpression in neoplasms
HSTNI - Overview: Troponin I, High Sensitivity, Plasma
Excluding the diagnosis of acute coronary syndromes Explaining troponin T elevations related to skeletal myopathy and/or assay interferences
TRIGC - Overview: Triglycerides, CDC, Serum
Measurement of triglycerides as part of lipoprotein profiling
PLAIF - Overview: Phospholipase A2 Receptor (PLA2R), Renal Biopsy
Distinguishing primary membranous nephropathy from secondary membranous nephropathy
ALPRT - Overview: Alport (Collagen IV Alpha 5 and Alpha 2) Immunofluorescent Stain, Renal Biopsy
Assisting in the diagnosis of hereditary nephritis (Alport syndrome)
KUR - Overview: Potassium, 24 Hour, Urine
Determining the cause for hyper- or hypokalemia
MMPM - Overview: Mumps Virus Antibody, IgM, Serum
Laboratory diagnosis of mumps virus infection
ISAE - Overview: Aerobe Identification by Sequencing (Bill Only)
Aerobe Identification by Sequencing (Bill Only)
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...